🔗 Share this article

The top legal official in Texas Paxton is suing the producers of acetaminophen, claiming the companies withheld alleged dangers that the pain reliever presented to pediatric cognitive development.

The court filing comes thirty days after Former President Trump promoted an unsubstantiated connection between taking Tylenol - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is filing suit against the pharmaceutical giant, which once produced the drug, the exclusive pain medication recommended for expectant mothers, and Kenvue, which now manufacturers it.

In a official comment, he said they "deceived the public by making money from suffering and pushing pills ignoring the potential hazards."

Kenvue asserts there is no credible evidence tying Tylenol to autism.

"These corporations misled for generations, knowingly endangering countless individuals to line their pockets," Paxton, from the Republican party, stated.

Kenvue stated officially that it was "very worried by the dissemination of inaccurate information on the reliability of paracetamol and the likely effects that could have on the health of American women and children."

On its website, Kenvue also said it had "continuously evaluated the relevant science and there is lacking reliable evidence that indicates a proven link between using acetaminophen and autism."

Groups speaking for doctors and healthcare providers concur.

ACOG has stated paracetamol - the key substance in Tylenol - is a restricted selection for women during pregnancy to manage pain and fever, which can present significant medical dangers if not addressed.

"In over twenty years of research on the utilization of acetaminophen in pregnancy, no reliable research has definitively established that the consumption of acetaminophen in any period of gestation causes neurodevelopmental disorders in children," the association stated.

The lawsuit references recent announcements from the previous government in arguing the medication is allegedly unsafe.

In recent weeks, Trump caused concern from public health officials when he advised women during pregnancy to "resist strongly" not to take acetaminophen when sick.

Federal regulators then issued a notice that medical professionals should think about restricting the consumption of acetaminophen, while also mentioning that "a direct connection" between the medication and autism spectrum disorder in children has not been established.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had promised in April to undertake "a massive testing and research effort" that would establish the source of autism in a short period.

But experts advised that identifying a sole reason of autism - thought by researchers to be the result of a complicated interplay of genetic and environmental factors - would not be simple.

Autism is a form of permanent neurological difference and impairment that impacts how individuals perceive and interact with the surroundings, and is recognized using doctors' observations.

In his lawsuit, the attorney general - a Trump ally who is campaigning for US Senate - asserts the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the evidence" around acetaminophen and autism.

The lawsuit aims to force the companies "eliminate any commercial messaging" that asserts acetaminophen is reliable for expectant mothers.

The Texas lawsuit parallels the complaints of a group of guardians of children with autism spectrum disorder and ADHD who took legal action against the manufacturers of Tylenol in 2022.

The court dismissed the legal action, declaring investigations from the plaintiffs' authorities was lacking definitive proof.